Skip to main content
Fig. 4 | Applied Biological Chemistry

Fig. 4

From: RETRACTED ARTICLE: Inhibition of human liver cancer cell growth by evodiamine involves apoptosis and deactivation of PI3K/AKT pathway

Fig. 4

Induction of apoptosis in liver cancer cells by evodiamine a Quantification of apoptotic cell percentage of evodiamine treated HepG2 and PLHC-1 cells by Annexin V/PI staining assay. Results showed that apoptotic cell percentage of the liver cancer cells increased remarkably with increasing evodiamine doses. b Western blotting assay showing increase in Bax and decrease in Bcl-2 expression in HepG2 and PLHC-1 cells. The experiments were performed in triplicate

Back to article page